QQ客服 官方微博 反馈留言

	Hepatic leukocyte immunoglobulin-like receptor B4 (LILRB4) attenuates nonalcoholic fatty liver disease via SHP1-TRAF6 pathway
	Lu, Yao; Jiang, Zhou; Dai, Haijiang; Miao, Rujia; Shu, Jingxian; Gu, Haotian; Liu, Xing; Huang, Zhijun; Yang, Guoping; Chen, Alex F.
刊名	HEPATOLOGY
	2018
卷号	67期号:4
ISSN号	0270-9139
DOI	10.1002/hep.29633
URL标识	查看原文
收录类别	SCIE
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4155290
专题	武汉大学
推荐引用方式 GB/T 7714	Lu, Yao,Jiang, Zhou,Dai, Haijiang,et al. Hepatic leukocyte immunoglobulin-like receptor B4 (LILRB4) attenuates nonalcoholic fatty liver disease via SHP1-TRAF6 pathway[J]. HEPATOLOGY,2018,67(4).
APA	Lu, Yao.,Jiang, Zhou.,Dai, Haijiang.,Miao, Rujia.,Shu, Jingxian.,...&Cai, Jingjing.(2018).Hepatic leukocyte immunoglobulin-like receptor B4 (LILRB4) attenuates nonalcoholic fatty liver disease via SHP1-TRAF6 pathway.HEPATOLOGY,67(4).
MLA	Lu, Yao,et al."Hepatic leukocyte immunoglobulin-like receptor B4 (LILRB4) attenuates nonalcoholic fatty liver disease via SHP1-TRAF6 pathway".HEPATOLOGY 67.4(2018).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。